Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21: s00441800924
DOI: 10.1055/s-0044-1800924
Original Article
Surgical Oncology

Is the Pressure from Blue Dye Cervical Injection Associated with Sentinel Lymph Node Detection in Laparoscopic Surgery for Endometrial Cancer?

Authors

  • Marcelo Simonsen

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
    2   Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, SP, Brazil
  • Marina Bandeira de Mello Amaral

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
  • Najla Mohamed Tayfour

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
  • Eric Vieira Luna Mayerhoff

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
  • Igor Marcondes de Andrade

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
  • Lais Moreira Silva

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
  • Marcelo Antonini

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil
  • Andressa Melina Severino Teixeira

    1   Gynecology and Obstetrics Department, Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, SP, Brazil

Funding The authors declare that they did not receive financial support from agencies in the public, private, or non-profit sectors to conduct the present study. Clinical Trials None.

Abstract

Introduction Sentinel lymph node biopsy (SLNB) has been proven to be a safe procedure in the treatment of endometrial cancer, and the instillment of a dye/marker in the cervix is the most used technique. Various studies have correlated the body mass index (BMI) impact as well as menopausal status and staging with the rate of lymph node detection, but few studies have evaluated if the high density of the cervix decreases detection.

Objective To quantify the injection pressure of the marker in the uterine cervix and to correlate it with the sentinel lymph node detection rate in endometrial neoplasia.

Materials and Methods Patients with endometrial cancer with programmed laparoscopic SLNB were selected to have the cervical injection pressure assessed. Immediately following the extraction of the uterus, saline solution was reapplied to measure injection pressure with a device attached to the syringe. We investigated the possible correlation of injection pressure with lymph node detection rate and the clinical data of the patients.

Results A total of 18 women participated in the study; a correlation between injection pressure and lymph node detection rate was not identified, neither was greater injection pressure detected in smaller uteruses or cervices. The pressure of the deep injection is greater than that of the superficial one, but the more medial application, or more lateral in relation to the midpoint, does not alter the injection pressure.

Conclusion The presence of greater resistance in the instillment of stain into the cervix was not associated with a lower lymph node detection rate.

Authors' Contributions

MS: collection and assembly of data, conception and design, data analysis and interpretation, final approval of the manuscript, writing of the manuscript, and provision of study materials or patient; MBMA: collection and assembly of data, conception and design, and writing of the manuscript; NT: conception and design and final approval of the manuscript; EVLLM: data analysis and interpretation, and provision of study materials or patient; IMA: collection and assembly of data and data analysis and interpretation; LM: collection and assembly of data, conception and design, and final approval of the manuscript; MA: final approval of the manuscript; AMST: conception and design, final approval of the manuscript, and provision of study materials or patient.




Publication History

Received: 28 August 2024

Accepted: 30 September 2024

Article published online:
29 January 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Marcelo Simonsen, Marina Bandeira de Mello Amaral, Najla Mohamed Tayfour, Eric Vieira Luna Mayerhoff, Igor Marcondes de Andrade, Lais Moreira Silva, Marcelo Antonini, Andressa Melina Severino Teixeira. Is the Pressure from Blue Dye Cervical Injection Associated with Sentinel Lymph Node Detection in Laparoscopic Surgery for Endometrial Cancer?. Brazilian Journal of Oncology 2025; 21: s00441800924.
DOI: 10.1055/s-0044-1800924
 
  • References

  • 1 2.2023 NGV. Uterine Neoplasms. National Comprehensive Cancer Network, 2023
  • 2 INCA INdCJAG-. Estimativa 2023 - Incidência de Câncer no Brasil Incidência de Câncer no Brasil. In: Saúde. Md, ed. Brazil: 2022
  • 3 Saúde Md. Manual de Atenção às Pessoas com Sobrepeso e Obesidade no Âmbito da Atenção Primária à Saúde (Aps) do Sistema Único de Saúde. In: Saúde DdPaod, ed. Brazil: 2022
  • 4 Accorsi GS, Paiva LL, Schmidt R, Vieira M, Reis R, Andrade C. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications. J Minim Invasive Gynecol 2020; 27 (04) 938-945.e2
  • 5 Zahl Eriksson AG, Ducie J, Ali N. et al. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol 2016; 140 (03) 394-399
  • 6 Rossi EC, Kowalski LD, Scalici J. et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017; 18 (03) 384-392
  • 7 Gu Y, Cheng H, Zong L, Kong Y, Xiang Y. Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis With Trial Sequential Analysis. Front Oncol 2021; 10: 580128
  • 8 Holloway RW, Abu-Rustum NR, Backes FJ. et al. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol 2017; 146 (02) 405-415
  • 9 Niikura H, Kaiho-Sakuma M, Tokunaga H. et al. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2013; 131 (02) 299-303
  • 10 Capozzi VA, Valentina C, Giulio S. et al. Sentinel node mapping in endometrial cancer: Tips and tricks to improve bilateral detection rate. The sentitricks study, a monocentric experience. Taiwan J Obstet Gynecol 2021; 60 (01) 31-35
  • 11 Khoury-Collado F, St Clair C, Abu-Rustum NR. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update. Oncologist 2016; 21 (04) 461-466
  • 12 Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 2017; 216 (05) 459-476.e10
  • 13 Persson J, Salehi S, Bollino M, Lönnerfors C, Falconer H, Geppert B. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer 2019; 116: 77-85
  • 14 Frumovitz M, Plante M, Lee PS. et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 2018; 19 (10) 1394-1403
  • 15 Tao S, Zhang Z, Li L. et al. Characteristics of systematic lymph node dissection and influencing factors of sentinel lymph node biopsy using carbon nanoparticles in endometrial carcinoma: a single-center study. World J Surg Oncol 2023; 21 (01) 39
  • 16 Eriksson AG, Montovano M, Beavis A. et al. Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery. Ann Surg Oncol 2016; 23 (08) 2522-2528
  • 17 Eriksson AGZ, Davidson B, Bjerre Trent P. et al. Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma. J Clin Med 2021; 10 (14) 10
  • 18 Tortorella L, Casarin J, Multinu F. et al. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping. Gynecol Oncol 2019; 155 (01) 34-38
  • 19 Wang T, Xu Y, Shao W, Wang C. Sentinel Lymph Node Mapping: Current Applications and Future Perspectives in Gynecology Malignant Tumors. Front Med (Lausanne) 2022; 9: 922585
  • 20 Concin N, Matias-Guiu X, Vergote I. et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021; 31 (01) 12-39
  • 21 Rocha A, Domínguez AM, Lécuru F, Bourdel N. Indocyanine green and infrared fluorescence in detection of sentinel lymph nodes in endometrial and cervical cancer staging - a systematic review. Eur J Obstet Gynecol Reprod Biol 2016; 206: 213-219
  • 22 Zhai L, Zhang X, Cui M, Wang J. Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review. Front Oncol 2021; 11: 701758
  • 23 Balaya V, Guani B, Pache B. et al. Sentinel lymph node in cervical cancer: time to move forward. Chin Clin Oncol 2021; 10 (02) 18
  • 24 Body N, Grégoire J, Renaud MC, Sebastianelli A, Grondin K, Plante M. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer. Gynecol Oncol 2018; 150 (02) 267-273
  • 25 Ruscito I, Gasparri ML, Braicu EI. et al. Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis. Ann Surg Oncol 2016; 23 (11) 3749-3756
  • 26 Taşkın S, Sarı ME, Altın D. et al. Risk factors for failure of sentinel lymph node mapping using indocyanine green/near-infrared fluorescent imaging in endometrial cancer. Arch Gynecol Obstet 2019; 299 (06) 1667-1672
  • 27 Eitan R, Sabah G, Krissi H. et al. Robotic blue-dye sentinel lymph node detection for endometrial cancer - Factors predicting successful mapping. Eur J Surg Oncol 2015; 41 (12) 1659-1663
  • 28 Lin H, Ding Z, Kota VG, Zhang X, Zhou J. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. Oncotarget 2017; 8 (28) 46601-46610
  • 29 Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol 2011; 123 (03) 522-527
  • 30 Conway WC, Faries MB, Nicholl MB. et al. Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol 2009; 16 (06) 1548-1552